A look at genetics and epigenetics in substance addiction

Main Article Content

Ricardo Sánchez Huesca
Liliana Berenice Templos Núñez

Abstract

Los trastornos por consumo de sustancias adictivas han demostrado tener una clara base genética y epigenética (Matus Ortega et al., 2012; Ruíz Contreras et al., 2010; Sanz, 2015). Se ha estimado que los factores genéticos pueden explicar entre 40% y 60% del desarrollo de la adicción, aunque la gran cantidad de polimorfismos encontrados dificulta la identificación de marcadores genéticos específicos (Kendler et al., 1994; Matus Ortega et al., 2012). Los genes son las unidades básicas funcionales de la herencia genética, se calcula que los seres humanos tienen entre 20 mil y 25 mil genes. El ácido desoxirribonucleico (ADN) es el material hereditario de los seres humanos y se encuentra en el núcleo celular, pero también una pequeña parte se localiza en las mitocondrias. En promedio, las secuencias de ADN de las personas son un 99.9% iguales, la variación del 0.1% representa tres millones de diferencias en los casi tres mil millones de pares de bases en la secuencia de ADN (Genetic Alliance, 2009). Esas diferencias contribuyen a variaciones evidentes como el color de ojos, cabello y altura, y a otras no evidentes como el mayor riesgo o protección de ataques cardiacos, cáncer, demencia o adicción a sustancias.

Published: Mar 29, 2022

Article Details

How to Cite
Sánchez Huesca, R. ., & Templos Núñez, L. B. . (2022). A look at genetics and epigenetics in substance addiction. Revista Internacional De Investigación En Adicciones, 8(1), 51–56. https://doi.org/10.28931/riiad.2022.1.06
Section
Experts Opinions

References

Anacker, C., O`Donnell, K., J., & Meaney, M. J. (2014). Early life adversity and the epigenetic programming of hypothalamic-pituitaryadrenal function. Dialogues in Clinical Neuroscience, 16(3), 31-333. doi: 10.31887/DCNS.2014.16.3/canacker

Armas, G., Pezoa, R. E., & Vásquez, J. A. (2010). Factor neurotrófico derivado del cerebro en el trastorno depresivo mayor. El Residente, 5(1), 19-21.

Barrueco, M. & González, R. (2012). Genotipo y dependencia nicotínica. Revista de Patología Respiratoria, 15(4), 97-100.

Bilbao, A., Rodríguez Parkitna, J., Engblom, D., Perreau-Lenz, S., Sanchis-Segura, C., Schneider, M., Konopka, Westphal, M., Breen, G., Desrivieres, S., Klugmann, M., Guindalini, C., Vallada, H., Laranjeira, R., Rodriguez de Fonseca, F., Schumann, G., Schütz, G., & Spanagel R. (2008). Loss of the Ca2/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine. Proceedings of the National Academy of Sciences of the United States of America, 105(45), 17549-17554. doi: 10.1073/pnas.0803959105

Brody, G. H., Beach, S. R. H., Philibert, R. A., Chen, Y., Lei, M. K., McBride Murry, V., & Brown, A. C. (2009). Parenting Moderates a Genetic Vulnerability Factor in Longitudinal Increases in Youths’ Substance Use. Journal of Consulting and Clinical Psychology, 77(1), 1-11. doi: 10.1037/a0012996

Cadet, J. L. (2016). Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications. Molecular Neurobiology, 53(1), 545-560. doi: 10.1007/s12035-014-9040-y

Cavalli, G. & Heard, E. (2019). Advances in epigenetics link genetics to the environment and disease. Nature, Nature Publishing Group, 571(7766), 489-499. doi: 10.1038/s41586-019-1411-0

Champagne, F., & Meaney, M. J. (2001) Like mother, like daughter: evidence for non-genomic transmission of parental behavior and stress responsivity. Progress in Brain Research, 133, 287-302. doi: 10.1016/s0079-6123(01)33022-4

Cummings, J. A., Gowl, B. A., Westenbroek, C., Clinton, S. M., Akil, H., & Becker, J. B. (2011)Effects of a selectively bred novelty-seeking phenotype on the motivation to take cocaine in male and female rats. Biology of Sex Differences, 2(3), 1-10. doi: 10.1186/2042-6410-2-3

Demontis, D., Rajagopal, V. M., Thorgeirsson, T. E., Als, T. D., Grove, J., Leppala, K., Gudbjartsson, D. F., Pallesen, J., Hjorthøj, C., Reginsson, G., Tyrfingsson, T., Runarsdottir, V., Qvist, P., Hvarregaard Christensen, J., Bybjerg-Grauholm, J., Bækvad-Hansen, M., Huckins, L. M., Stahl, E. A., Timmermann, A. … Børglum, A. D. (2019) Genome-wide association study implicates CHRNA2 in cannabis use disorder. Nature Neuroscience, 22(7), 1066-1074. doi: 10.1038/s41593-019-0416-1

Díaz-Anzaldúa, A., Velázquez-Pérez, J., Nani-Vázquez, A., & Berlanga, C. (2013). Endophenotypes and biomarkers: an approach to molecular genetic studies of mental disorders. Salud Mental, 36,181-188.

Enoch, M. A. (2011). The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology, 214(1), 17-31. doi: 10.1007/s00213-010-1916-6

Genetic Alliance. (2009). Cómo entender la genética: una guía para pacientes y profesionales médicos en la región de Nueva York y el Atlántico Medio. Nueva York: The New York – Mid‐Atlantic Consortium for Genetic and Newborn Screening Services.

Gerra, G., Zaimovic, A., Castaldini, L., Garofano, L., Manfredini, M., Somaini, L., Gerra, M. L., & Donnini, C. (2010). Relevance of Perceived Childhood Neglect, 5-HTT Gene Variants and Hypothalamus–Pituitary–Adrenal Axis Dysregulation to Substance Abuse Susceptibility. American Journal of Medical Genetics Part B,153B, 715-722.

Gerra, G., Zaimovic, A., Garofano, L., Ciusa, F., Moi, G., Avanzini, P., Talarico, E. Gardini. F., Brambilla, F., Manfredini, M., Donnini, C. (2007). Perceived Parenting Behavior in the Childhood of Cocaine Users: Relationship With Genotype and Personality Traits. American Journal of Medical Genetics Part B 144B, 52-57.

Goldman, D., Oroszi, G., & Ducci, F. (2005). The Genetics of Addictions: Uncovering the genes. Nature Reviews, 6, 521-32.

Gorwood, P., Le Strat, Y., Ramoz, N., Dubertret, C., Moalic, J. M., & Simonneau, M. (2012). Genetics of dopamine receptors and drug addiction. Human Genetics, 131, 803-822. doi: 10.1007/s00439-012-1145-7

Harari, O., Wang, J. C., Bucholz, K., Edenberg, H. J., Heath, A., Martin, N. G., Pergadia, M. L., Montgomery, G., Schrage, A., Bierut, L. J., Madden, P. F., & Goate, A. M. (2012). Pathway analysis of smoking quantity in multiple GWAS identifies cholinergic and sensory pathways. PLoS One, 7, e50913. doi: 10.1371/journal.pone.0050913

Hopfer, C. J., Young, S. E., Purcell, S., Crowley, T. J., Stallings, M. C., Corley, R. P., Rhee, S. H., Smolen, A., Krauter, K., Hewitt, J. K. & Ehringer, M. A. (2006). Cannabis Receptor Haplotype Associated With Fewer Cannabis Dependence Symptoms in Adolescents. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(8), 895-901. doi: 10.1002/ajmg.b.30378

Ibañez, A. (2008). Genética de las adicciones. Adicciones, 20(2), 103-110.

Kendler, K. S., Neale, M. C., Heath, A. C., Kessler, R. C., & Eaves, L. J. (1994). A twin-family study of alcoholism in women. The American Journal of Psychiatry, 151, 707-715 (1994). doi: 10.1176/ajp.151.5.707

Kim, P., Evans, G. W., Ansgtadt, M., Ho, S., Sripada, C. S., Swain, J. E., Liberzon, I., & Phan, L. K. (2013). Effects of childhood poverty and chronic stress on emotion regulatory brain function in adulthood. Proceedings of the National Academy of Science of the United States of America, 10(46), 18442-18447. doi: 10.1073/pnas.1308240110

Korinek, K., Teerawichitchainan, B., Zimmer, Z., Brindle, E., Kim Chuc, N. T., Minh, N. H., & Toan K. T. (2019). Design and measurement in a study of war exposure, health, and aging: protocol for the Vietnam health and aging study. BMC Public Health, 19, 1351. doi: 10.1186/s12889-019-7680-6

Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A., Bromberg, E., & de Vries, E. F. J. (2019). Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. Molecular Neurobiology, 56, 3295-3312. doi: 10.1007/s12035-018-1283-6.

Liu, M., Fan, R., Liu, X., Cheng, F., & Wang, J. (2015). Pathways and networks-based analysis of candidate genes associated with nicotine addiction. PLoS One, 10, e0127438. doi: 10.1371/journal.pone.0127438

Matus Ortega, M., Calva Nieves, J. C., Flores Zamora, A., Leff Gelman, P. & Antón Palma, B. (2012). Las adicciones, hallazgos genómicos. Salud Mental, 35, 129-135.

McNerney, M. W., Sheng, T., Nechvatal., J. M., Lee., A. G., Lyons, D. M., Soman, S., Liao, C. P., O’Hara, R., Hallmayer, J., Taylor, J. Ashford,J. W., Yesavage,J.,& Adamson, M. M. (2018) Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volumen and glucocorticoid receptor gene methylation. PLoS ONE, 13(2), e0192222. doi: 10.1371/journal.pone.0192222

Mills-Koonce, W. R., Gariépy, J. L., Propper, C., Sutton, K., Calkins, S., Moore, G., & Cox, M. (2007). Infant and parent factors associated with early maternal sensitivity: A caregiver-attachment systems approach. Infant Behavior & Development, 30, 114-126. doi: 10.1016/j.infbeh.2006.11.010

Minica, C. C., Mbarek, H., Pool, R., Dolan, C. V., Boomsma, D. I., & Vink, J. M. (2017). Pathways to smoking behaviours: Biological insights from the Tobacco and Genetics Consortium meta-analysis. Molecular Psychiatry, 22, 82-88. doi: 10.1038/mp.2016.20

Minton, J., Vanderbloemen, L., & Dorling, D. (2013). Visualizing Europe’s demographic scars with coplots and contour plots. International Journal of Epidemiology, 42, 1164-1176. doi: 10.1093/ije/dyt115

Miranda, A. L., López Jaramillo, C., García Valencia, J., & Ospina Duque, J. (2003). El uso de endofenotipos en el estudio del componente genético de la esquizofrenia. Revista Colombiana de Psiquiatría, 32(3), 237- 248.

Mulligan, M. K. (2019). Genetic Factors in Cannabinoid Use and Dependence. Recent Advances in Cannabinoid Physiology and Pathology, 129-149. doi: 10.1007/978-3-030-21737-2_7

Mwenifumbo, J. C., Lessov-Schlaggar, C. N., Zhou, Q., Krasnow, R. E., Swan, G. E., Benowitz, N. L., & Tybdale, R. F. (2008). Identification of novel CYP2A6*1B variants: The CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Clinical Pharmacology & Therapeutics, 83, 115-121.

Nemeroff, C. B. (2016). Paradise Lost: The Neurobiological and Clinical Consequences of Child Abuse and Neglect. Neuron, 89, 892- 909. doi: 10.1016/j.neuron.2016.01.019

Palma-Álvarez, R. F., Ros-Cucurull, E., Amaro-Hosey, K., Rodriguez-Cintas, L., Grau-López, L., Corominas-Roso, M., Sánchez-Mora, C., & Roncero, C. (2017). Peripheral levels of BDNF and opiate-use disorder: literature review and update. Reviews in the Neurosciences, 28(5), 499-508. doi: 10.1515/revneuro-2016-0078

Pastor, V., Antonelli, M. C. & Pallarés, M. E. (2017). Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder. Neurotoxicity Research, 31(1), 169-186. doi: 10.1007/s12640-016-9674-9

Peña, C. J., Kronman, H. G., Walker, D. M., Cates, H. M., Bagot, R. C., Purushothaman, I., Issler, O., Loth, Y. E., Leong, T., Kiraly, D. D., Goodman, E., Neve, R. L., Shen, L., & Nestler, E. J. (2017). Early life stress confers lifelong stress susceptibility in mice via ventral tegmental area OTX2. Science, 356, 1185-1188. doi: 10.1126/science.aan4491

Pianezza, M. L., Sellers, E. M., & Tyndale, R. F., (1998). Nicotine metabolism defect reduces smoking. Nature, 393, 750.

Prom-Wormley, E. C., Ebejer, J., Dick, D. M., & Bowers, M. S. (2017). The genetic epidemiology of substance use disorder: A Review. Drug and Alcohol Dependence, 180, 241-259. doi: 10.1016/j.drugalcdep.2017.06.040

Ramo-Fernández, L., Schneider, A., Wilker, S., & Kolassa, I. T. (2015). Epigenetic Alterations Associated with War Trauma and Childhood Maltreatment. Behavioral Sciences The Law, 33, 701-721. doi: 10.1002/bsl.2200

Reilly, M. T., Noronha, A., Goldman, D., & Koob, G. F. (2017). Genetic studies of alcohol dependence in the context of the addiction cycle. Neuropharmacology, 122, 3-21. doi: 10.1016/j.neuropharm.2017.01.017

Ruíz Contreras, A., Méndez, M., Prieto, B., Romano, A., Caynas, S., & Prospéro, O. (2010). El cerebro, las drogas y los genes. Salud Mental, 33, 535-542.

Sanz, M. J. M. (2015). Epigenética y trastornos psiquiátricos. Pediatría Integral, 524-531.

Shoji, H., & Kato, K. (2009). Maternal care affects the development of maternal behavior in inbred mice. Developmental Psychobiology, 51(4), 345-357. doi: 10.1002/dev.20375

Straight, B., Fisher, G., Needham, B. L., Naugle, A., Olungah, C., Wantijirattikal, P., Root, C., Farman, J., Barkman, T., & Lalancette, C. (2020). Lifetime stress and war exposure timing may predict methylation changes at NR3C1 based on a pilot study in a warrior cohort in a small-scale society in Kenya. American Journal of Human Biology, 33(4), 1-18. doi: 10.1002/ajhb.23515

Trivedi, M. S., Abreu, M. M., Sarria, L., Rose, N., Ahmed, D., Beljanski, V., Flethcer, M. A., Klimas, N., & Nathanson, L. (2019). Alterations in DNA Methylation Status Associated with Gulf War Illness. DNA and Cell Biology, 38(6), 561-571. doi: 10.1089/dna.2018.4469

Volkow, N. D., & Muenke, M. (2012). The genetics of addiction. Human Genetics, 131, 773–777. doi: 10.1007/s00439-012-1173-3